Using the EuroQoI 5-D in the Catalan general population: feasibility and construct validity.

Catalan Institute of Public Health, Universitat de Barcelona, Spain.
Quality of Life Research (Impact Factor: 2.86). 06/1998; 7(4):311-22. DOI: 10.1023/A:1024933913698
Source: PubMed

ABSTRACT Spanish and Catalan versions of the EuroQoi 5-D (EQ-5D) were included in the Catalan Health Interview Survey (CHIS) and administered to a randomly selected cross-section of 12,245 individuals from the Catalan general population. This paper analyses the feasibility, convergent validity and construct validity of three parts of the EQ-5D (the descriptive system, the visual analogue scale (VAS) and the Spanish tariff) using the results obtained in the CHIS. The feasibility was assessed by the number of missing responses. The convergent validity was based on the correlations between the EQ-5D scores and the scores on the General Health Questionnaire (GHQ) and on an index of self-perceived overall health. The construct validity was assessed by analysing the degree to which lower scores on the EQ-5D correlated positively with increasing age, being female, being in a lower social class or having a lower level of education and with increasing levels of disability, co-morbidity, restricted activity, mental health problems and poor self-perceived health. A low number of missing responses on the descriptive system and the VAS (1.5%) indicated a high level of acceptance. A marked ceiling effect was found, with 67% of the sample reporting no problem in any EQ dimension. The convergent validity with the GHQ was generally low, though moderate on the mood dimension. Self-perceived overall health correlated moderately to strongly with the mean VAS and tariff values. The positive correlations between lower scores on all three elements of the EQ-5D and increasing age, increasing levels of disability, comorbidity, restricted activity, mental health problems and poor self-perceived health provide some evidence of the instrument's construct validity, as does the fact that women reported more problems than men. Multivariate analyses using the VAS and tariff values as dependent variables and all of the sociodemographic and health variables as independent variables reached R2 values of 0.45 and 0.81, respectively. The Spanish and Catalan versions of the EQ-5D have proved to be feasible and valid for use in health interview surveys.

  • [Show abstract] [Hide abstract]
    ABSTRACT: OBJECTIVE:When patients with Crohn’s disease (CD) express concerns about their disease, they emphasize worries about surgery. However, most studies about the impact of surgery in CD on health-related quality of life (HRQOL) have compared postsurgical changes on HRQOL relative to HRQOL before surgery, not taking into account the influence of CD activity on HRQOL. Our aim was to assess whether surgical treatment of CD modifies HRQOL, compared with inactive CD, active CD, or healthy controls.METHODS:Outcomes of 29 CD patients in remission with a previous bowel resection were compared with those from 42 clinically active CD patients and 48 patients with medically induced remission. A reference control group of 63 healthy individuals was also studied. HRQOL was measured by the Inflammatory Bowel Disease Questionnaire (IBDQ), the Psychological General Well Being Index (PGWBI), and the EuroQol.RESULTS:Active CD patients scored the lowest on the IBDQ. Both operated and nonoperated inactive CD patients had lower HRQOL scores than controls in overall IBDQ and in all five domains. However, neither global score, digestive, systemic, emotional, social, or functional dimensions differed significantly between operated and nonoperated inactive CD patients. PGWBI and the visual analog scale of the EuroQol were also similar in both groups of inactive CD patients (103 [range, 94–107] vs 103 [97–106] and 90 [73–87] vs 82 [76–84]), but significantly higher than in active CD.CONCLUSIONS:HRQOL is impaired in active CD, and improves during remission irrespective of whether it had been achieved medically or surgically. Our results suggest that to improve HRQOL it is more important to achieve remission than the approach, drugs or surgery, chosen.
    The American Journal of Gastroenterology 01/2000; 95(1):177-182. DOI:10.1016/S0002-9270(99)00740-6 · 9.21 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The EQ-5D is a health-related quality of life instrument which provides a simple descriptive health profile and a single index value for health status. The latest version, the EQ-5D-5L, has been translated into more than one hundred languages worldwide - including Thai. This study aims to assess the measurement properties of the Thai version of the EQ-5D-5L (the 5L) compared to the EQ-5D-3L (the 3L). A total of 117 diabetes patients treated with insulin completed a questionnaire including the 3L and the 5L. The 3L and 5L were compared in terms of distribution, ceiling, convergent validity, discriminative power, test-retest reliability, feasibility, and patient preference. Convergent validity was tested by assessing the relationship between each dimension of the EQ-5D and SF-36v2 using Spearman's rank-order correlation. Discriminative power was determined by the Shannon index (H ') and Shannon's Evenness index (J '). The test-retest reliability was assessed by examining the intraclass correlation coefficient (ICC) and Cohen's weighted kappa coefficient. No inconsistent response was found. The 5L trended towards a slightly lower ceiling compared with the 3L (33% versus 29%). Regarding redistribution, 69% to 100% of the patients answering level 2 with the 3L version redistributed their responses to level 2 with the 5L version while about 9% to 22% redistributed their responses to level 3 with the 5L version. The Shannon index (H ') improved with the 5L while the Shannon's Evenness index (J ') reduced slightly. Convergent validity and test-retest reliability was confirmed for both 3L and 5L. Evidence supported the convergent validity and test-retest reliability of both the 3L and 5L in diabetes patients. However, the 5L is more promising compared to the 3L in terms of a lower ceiling, more discriminatory power, and higher preference by the respondents. Thus, the 5L should be recommended as a preferred health-related quality of life measure in Thailand.
    Health and Quality of Life Outcomes 12/2015; 13(1). DOI:10.1186/s12955-014-0203-3 · 2.10 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Background Clinical practice guidelines for the treatment of major depressive disorder (MDD) recommend antidepressants for patients with moderate-severe depression and active monitoring for patients with mild-moderate symptoms. The feasibility and efficiency of active monitoring has not been proven conclusively. The aim of this study is to evaluate the cost-effectiveness of active monitoring in comparison to antidepressants for primary care patients with mild-moderate MDD. Methods/Design This is a 12-month follow-up multicenter observational prospective controlled trial. Patients are enrolled in 12 primary care centers in Barcelona (Spain). Eligible patients are adults (≥18 years-old) with a new episode of MDD that sign a written consent to participate. This is a naturalistic study in which general practitioners (GPs) use their professional judgment to allocate patients into active monitoring or antidepressants groups. GPs treat the patients following their clinical criteria. At baseline, GPs complete a questionnaire (sociodemographic/job characteristics, training, attitude towards depression, interest on mental health and participation in communication groups). Patients’ measurements take place at baseline and after six and 12 months. Main outcome measures include severity of depression (PHQ-9), health-related quality of life (EuroQol-5D) and use of healthcare and social care services (Client Service Receipt Inventory). Secondary outcomes include diagnosis of MDD according to DSM-IV diagnostic criteria (SCID-I), disability (WHO-DAS), anxiety (BAI), comorbidities, medication side-effects and beliefs about medicines (BMQ). The analysis will be done according to the intention to treat analysis. Missing data will be imputed using multiple imputation by chained equations. To minimize the bias resulting from the lack of randomization, a propensity score will be used. Incremental effects and costs between groups will be modelled in each of the imputed databases using multivariate generalized linear models and then combined as per Rubin’s rules. Propensity scores will be used to adjust the models. Incremental cost-effectiveness ratios will be calculated by dividing the difference in costs between groups by the difference in effects. To deal with the uncertainty, resampling techniques with bootstrapping will be used and cost-effectiveness planes and cost-effectiveness acceptability curves will be constructed. A series of sensitivity analyses will be performed. Discussion Given the high burden and costs generated by depressive disorder, it is important that general practitioners treat major depression efficiently. Recent evidence has suggested that antidepressants have low benefits for patients with mild to moderate major depression. For such cases of depression, active monitoring exists as a treatment option, but it is not without difficulties for implementation and its effectiveness and efficiency have not been demonstrated conclusively. The results of the study will provide information on which is the most efficient approach to treat patients with mild to moderate major depression in primary care. Trial registration NCT02245373
    BMC Psychiatry 03/2015; 15(63). DOI:10.1186/s12888-015-0448-3 · 2.24 Impact Factor